Volume 187 - Issue 1

Revisiting the metabolic syndrome

Authors:  Gerard T Chew, Seng Khee Gan and Gerald F Watts

Med J Aust 2007; 187 (1): 61. || doi: 10.5694/j.1326-5377.2007.tb01132.x
Published online: 2 July 2007

In reply: We thank Tuomainen for his interest in our review article, and for sharing with us his data showing an inverse association between fasting serum insulin levels and calculated serum free testosterone levels. We were cautious in our statement about the relationship between hyperinsulinaemia and free testosterone levels, as there are conflicting data in the literature regarding this,1,2 and few studies that directly measure free or bioavailable testosterone. Moreover, there is ongoing controversy about the calculation of free testosterone levels using total testosterone and sex hormone-binding globulin concentrations, with the validity and assumptions of some of these widely used estimation equations being called into question.3,4

We also echo the concerns of Allan et al5 about the potential pitfalls of diagnosing hypogonadism based on testosterone levels only. As the presence of low total (and even calculated free) testosterone in obese men may not necessarily reflect deficient androgen action, the diagnosis of androgen deficiency should only be made in the context of supportive clinical features. Furthermore, in abdominally obese men with the metabolic syndrome, levels of sex hormone-binding globulin and both total and calculated free testosterone can increase following weight loss,6 thereby obviating the inappropriate use of testosterone supplementation in such patients.


Authors


References